Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 09:50 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | BIOTECHNOLOGY VALUE FUND L P | 3,479,043 5.3% | 1,023,954 (+41.71%) | View |
| 2024-02-14 09:47 am Purchase | 13G | IKENA ONCOLOGY INC IKNA | BIOTECHNOLOGY VALUE FUND L P | 4,769,164 9.9% | 2,266,093 (+90.53%) | View |
| 2024-02-14 09:45 am Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,259,476 3.5% | -551,359 (-30.45%) | View |
| 2024-02-14 09:43 am Purchase | 13G | JANUX THERAPEUTICS INC JANX | BIOTECHNOLOGY VALUE FUND L P | 4,579,818 9.9% | 472,873 (+11.51%) | View |
| 2024-02-14 09:41 am Sale | 13G | JASPER THERAPEUTICS INC JSPR | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -9,900,000 (Position Closed) | View |
| 2024-02-14 09:39 am Purchase | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 7,373,228 9.9% | 3,572,245 (+93.98%) | View |
| 2024-02-14 09:37 am Purchase | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | BIOTECHNOLOGY VALUE FUND L P | 24,435,632 9.98% | 8,286,453 (+51.31%) | View |
| 2024-02-14 09:35 am Sale | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 2,752,420 4.8% | -226,000 (-7.59%) | View |
| 2024-02-14 09:33 am Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BIOTECHNOLOGY VALUE FUND L P | 537,426 9.99% | 537,426 (New Position) | View |
| 2024-02-14 09:31 am Purchase | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | BIOTECHNOLOGY VALUE FUND L P | 5,763,948 9.99% | 738,048 (+14.68%) | View |
| 2024-02-14 09:28 am Sale | 13G | PYXIS ONCOLOGY INC PYXS | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,938,851 (Position Closed) | View |
| 2024-02-14 09:26 am Sale | 13G | REVOLUTION MEDICINES INC RVMD | BIOTECHNOLOGY VALUE FUND L P | 5,981,212 3.6% | -1,574,376 (-20.84%) | View |
| 2024-02-14 09:24 am Purchase | 13G | TYRA BIOSCIENCES INC TYRA | BIOTECHNOLOGY VALUE FUND L P | 2,739,595 6.4% | 267,268 (+10.81%) | View |
| 2024-02-14 09:22 am Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,302,094 (Position Closed) | View |
| 2024-02-14 09:20 am Purchase | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.99% | 2,617,402 (New Position) | View |
| 2024-01-29 5:13 pm Sale | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -3,526,729 (Position Closed) | View |
| 2024-01-29 4:31 pm Unchanged | 13G | GLYCOMIMETICS INC GLYC | BIOTECHNOLOGY VALUE FUND L P | 9,544,262 14.8% | 0 (Unchanged) | View |
| 2024-01-18 4:32 pm Purchase | 13G | ALLAKOS INC ALLK | BIOTECHNOLOGY VALUE FUND L P | 16,552,417 18.9% | 8,000,000 (+93.54%) | View |
| 2024-01-18 4:29 pm Purchase | 13G | ALLAKOS INC ALLK | BIOTECHNOLOGY VALUE FUND L P | 8,552,417 9.8% | 3,545,496 (+70.81%) | View |
| 2024-01-18 4:18 pm Purchase | 13G | IMMUNIC INC IMUX | BIOTECHNOLOGY VALUE FUND L P | 8,902,972 9.9% | 8,902,972 (New Position) | View |